These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 6130677)
1. Short-term influence of a post-synaptic alpha-adrenoceptor blocking drug (prazosin) on carbohydrate metabolism. Waern AU; Berne C; Wibell L; Lithell H Acta Med Scand Suppl; 1982; 665():75-7. PubMed ID: 6130677 [TBL] [Abstract][Full Text] [Related]
2. Effect of alpha-1-blockade by prazosin on blood sugar, insulin and glucagon levels in normals and non-insulin dependent diabetics. Ferlito S; Puleo F; Carrà G; Damante G; Di Vincenzo S; Del Campo F J Endocrinol Invest; 1983 Jun; 6(3):199-202. PubMed ID: 6137500 [TBL] [Abstract][Full Text] [Related]
3. The pharmacology of prazosin, an alpha 1-adrenoceptor antagonist and the basis for its use in the treatment of essential hypertension. Davey MJ Clin Exp Hypertens A; 1982; 4(1-2):47-59. PubMed ID: 6122521 [TBL] [Abstract][Full Text] [Related]
4. Metabolic effects of chronic prazosin treatment. Barbieri C; Ferrari C; Borzio M; Piepoli V; Caldara R Horm Metab Res; 1980 Jul; 12(7):331-4. PubMed ID: 6105121 [TBL] [Abstract][Full Text] [Related]
5. Glucose metabolism during long-term treatment with prazosin. Lithell H; Berne C; Waern AU; Wibell L Diabetes Res; 1985 Nov; 2(6):297-9. PubMed ID: 3907930 [TBL] [Abstract][Full Text] [Related]
6. Enhancement of insulin secretion during selective blockade of alpha 1- and alpha 2-adrenoceptors in the rat: effects of somatostatin. Ahrén B; Järhult J; Lundquist I Acta Physiol Scand; 1982 Jun; 115(2):257-60. PubMed ID: 6127872 [TBL] [Abstract][Full Text] [Related]
7. The role of alpha- and beta-adrenoceptor subtypes in mediating the effects of catecholamines on fasting glucose and insulin concentrations in the rat. John GW; Doxey JC; Walter DS; Reid JL Br J Pharmacol; 1990 Aug; 100(4):699-704. PubMed ID: 1976400 [TBL] [Abstract][Full Text] [Related]
8. Effects of alpha 1-, alpha 2- and beta-adrenoceptor blockers on insulin secretion in the rat. Ahrén B; Lundquist I; Järhult J Acta Endocrinol (Copenh); 1984 Jan; 105(1):78-82. PubMed ID: 6141689 [TBL] [Abstract][Full Text] [Related]
9. Metabolic effects of prazosin. Barbieri C; Caldara R; Ferrari C; Dal Bo GA; Paracchi A; Romussi M; Curtarelli G Clin Pharmacol Ther; 1980 Mar; 27(3):313-6. PubMed ID: 6102000 [TBL] [Abstract][Full Text] [Related]
10. Comparison of cardiovascular effects of SGB-1534 and prazosin, selective alpha 1-adrenoceptor antagonists, in anesthetized dogs. Imagawa J; Nabata H; Sakai K Jpn J Pharmacol; 1987 May; 44(1):35-41. PubMed ID: 2887683 [TBL] [Abstract][Full Text] [Related]
11. Relationship between the hypotensive and alpha-adrenoceptor blocking actions of prazosin. Oates HF Arch Int Pharmacodyn Ther; 1979 Feb; 237(2):282-7. PubMed ID: 39527 [TBL] [Abstract][Full Text] [Related]
12. Alpha-blocking potencies of antihypertensive agents (prazosin, terazosin, bunazosin, SGB-1534 and ketanserin) having with quinazoline or quinazolinedione as assessed by radioligand binding assay methods in rat brain. Tsuchihashi H; Nagatomo T J Pharmacobiodyn; 1989 Mar; 12(3):170-4. PubMed ID: 2569512 [TBL] [Abstract][Full Text] [Related]
17. The alpha-adrenergic blocking effect of prazosin on the human prostate. Shapiro A; Mazouz B; Caine M Urol Res; 1981; 9(1):17-20. PubMed ID: 6115493 [TBL] [Abstract][Full Text] [Related]
18. Alpha 1-Adrenoceptor blockade: dissociation of its effects on renin release and arterial blood pressure in man. Morganti A; Sala C; Palermo A; Turolo L; Zanchetti A Clin Sci (Lond); 1981 Dec; 61 Suppl 7():307s-309s. PubMed ID: 6274574 [TBL] [Abstract][Full Text] [Related]